Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert W Strauss

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
American Journal of Ophthalmology|June 15, 2016
Comparison of Short-Wavelength Reduced-Illuminance and Conventional Autofluorescence Imaging in Stargardt Macular DystrophyRupert W Strauss, Beatriz Muñoz, Anamika Jha, et al.
Translational Vision Science & Technology|July 2, 2019
Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt DiseaseXiangrong Kong, Alexander Ho, Beatriz Munoz, et al.
American Journal of Ophthalmology|November 18, 2023
Progression of PROM1-Associated Retinal Degeneration as Determined by Spectral-Domain Optical Coherence Tomography Over a 24-Month PeriodManuel Großpötzl, Regina Riedl, Gernot Schließleder, et al.
Ophthalmology|May 28, 2017
Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6Xiangrong Kong, Rupert W Strauss, Artur V Cideciyan, et al.
JAMA Ophthalmology|June 15, 2018
Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10Xiangrong Kong, Kaoru Fujinami, Rupert W Strauss, et al.
American Journal of Ophthalmology|July 23, 2021
Longitudinal Changes of Fixation Stability and Location Within 24 Months in Stargardt Disease: ProgStar Report No. 16Etienne M Schönbach, Rupert W Strauss, Marco E G V Cattaneo, et al.
JAMA Ophthalmology|May 26, 2017
Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5Rupert W Strauss, Beatriz Muñoz, Alex Ho, et al.
Ophthalmology. Retina|May 4, 2019
Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4Xiangrong Kong, Sheila K West, Rupert W Strauss, et al.
JAMA Ophthalmology|October 20, 2017
Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9)Rupert W Strauss, Beatriz Muñoz, Alexander Ho, et al.
American Journal of Ophthalmology|March 31, 2020
Faster Sensitivity Loss around Dense Scotomas than for Overall Macular Sensitivity in Stargardt Disease: ProgStar Report No. 14Etienne M Schönbach, Rupert W Strauss, Mohamed A Ibrahim, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
American Journal of Ophthalmology|June 15, 2016
Comparison of Short-Wavelength Reduced-Illuminance and Conventional Autofluorescence Imaging in Stargardt Macular DystrophyRupert W Strauss, Beatriz Muñoz, Anamika Jha, et al.
Translational Vision Science & Technology|July 2, 2019
Reproducibility of Measurements of Retinal Structural Parameters Using Optical Coherence Tomography in Stargardt DiseaseXiangrong Kong, Alexander Ho, Beatriz Munoz, et al.
American Journal of Ophthalmology|November 18, 2023
Progression of PROM1-Associated Retinal Degeneration as Determined by Spectral-Domain Optical Coherence Tomography Over a 24-Month PeriodManuel Großpötzl, Regina Riedl, Gernot Schließleder, et al.
Ophthalmology|May 28, 2017
Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6Xiangrong Kong, Rupert W Strauss, Artur V Cideciyan, et al.
JAMA Ophthalmology|June 15, 2018
Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10Xiangrong Kong, Kaoru Fujinami, Rupert W Strauss, et al.
American Journal of Ophthalmology|July 23, 2021
Longitudinal Changes of Fixation Stability and Location Within 24 Months in Stargardt Disease: ProgStar Report No. 16Etienne M Schönbach, Rupert W Strauss, Marco E G V Cattaneo, et al.
JAMA Ophthalmology|May 26, 2017
Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5Rupert W Strauss, Beatriz Muñoz, Alex Ho, et al.
Ophthalmology. Retina|May 4, 2019
Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4Xiangrong Kong, Sheila K West, Rupert W Strauss, et al.
JAMA Ophthalmology|October 20, 2017
Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9)Rupert W Strauss, Beatriz Muñoz, Alexander Ho, et al.
American Journal of Ophthalmology|March 31, 2020
Faster Sensitivity Loss around Dense Scotomas than for Overall Macular Sensitivity in Stargardt Disease: ProgStar Report No. 14Etienne M Schönbach, Rupert W Strauss, Mohamed A Ibrahim, et al.
Pageof 6